| Company | Date | Position | Consensus β | Price Target β | 1-Yr Return | vs S&P 500 β |
|---|---|---|---|---|---|---|
|
SYK
Stryker
|
Oct 29, 2026 | BUY |
Strong Buy
+18.5% avg upside
38 analysts
|
$304.00
4.15% Upside
|
-0.3% | Β· |
|
GKOS
Glaukos
|
Oct 28, 2026 | BUY |
Strong Buy
-18.6% avg upside
21 analysts
|
$234.00
1.60% Downside
|
+34.1% | Β· |
|
KIDS
OrthoPediatrics
|
Oct 28, 2026 | BUY |
Strong Buy
+9.5% avg upside
10 analysts
|
$30.00
2.76% Downside
|
+2.0% | Β· |
|
IART
Integra Lifesciences
|
Oct 21, 2026 | HOLD |
Buy
+208.0% avg upside
22 analysts
|
β | +14.4% | Β· |
|
ISRG
Intuitive Surgical
|
Oct 20, 2026 | BUY |
Strong Buy
+12.0% avg upside
37 analysts
|
$454.00
5.11% Upside
|
-3.9% | Β· |
|
RCEL
Avita Medical
|
Oct 12, 2026 | BUY |
Strong Buy
-15.9% avg upside
11 analysts
|
$15.00
4.20% Downside
|
+16.9% | Β· |
|
MDT
Medtronic
|
Oct 12, 2026 | BUY |
Buy
+4.4% avg upside
38 analysts
|
$99.00
2.49% Upside
|
+11.9% | Β· |
|
ATRC
Atricure
|
Oct 12, 2026 | BUY |
Strong Buy
-13.7% avg upside
15 analysts
|
$63.00
2.92% Upside
|
-4.0% | Β· |
|
DXCM
Dexcom
|
Oct 12, 2026 | BUY |
Strong Buy
+31.4% avg upside
33 analysts
|
$96.00
16.64% Upside
|
-4.5% | Β· |
|
SI
Shoulder Innovations, Inc.
|
Oct 12, 2026 | BUY |
Strong Buy
+24.4% avg upside
5 analysts
|
$27.00
41.11% Upside
|
+12.8% | Β· |
|
CARL
Carlsmed, Inc.
|
Oct 12, 2026 | BUY |
Strong Buy
+25.4% avg upside
6 analysts
|
$24.00
60.52% Upside
|
+20.0% | Β· |
|
GEHC
GE Healthcare Technologies Inc
|
Oct 12, 2026 | BUY |
Strong Buy
+10.2% avg upside
23 analysts
|
$75.00
2.03% Downside
|
+20.9% | Β· |
|
TCMD
Tactile Systems Technology
|
Oct 12, 2026 | BUY |
Strong Buy
+74.3% avg upside
8 analysts
|
$35.00
51.83% Upside
|
+15.2% | Β· |
|
ZBH
Zimmer Biomet Holdings
|
Oct 09, 2026 | HOLD |
Buy
+20.5% avg upside
39 analysts
|
β | +15.8% | Β· |
|
SOLV
Solventum Corporation
|
Oct 09, 2026 | BUY |
Buy
+12.8% avg upside
16 analysts
|
$95.00
16.88% Upside
|
-1.4% | Β· |
|
DCTH
Delcath Systems
|
Oct 09, 2026 | BUY |
Strong Buy
+55.2% avg upside
12 analysts
|
$21.00
49.62% Upside
|
+26.1% | Β· |
|
ENOV
Enovis
|
Oct 02, 2026 | BUY |
Strong Buy
+226.7% avg upside
39 analysts
|
$36.00
80.83% Upside
|
+53.2% | Β· |
|
SNN
Smith & Nephew Snats
|
Sep 21, 2026 | HOLD |
Buy
+9.7% avg upside
15 analysts
|
β | +11.5% | Β· |
|
GMED
Globus Medical
|
Sep 18, 2026 | HOLD |
Strong Buy
+18.9% avg upside
24 analysts
|
β | -4.1% | Β· |
|
PRCT
PROCEPT BioRobotics
|
Aug 31, 2026 | HOLD |
Buy
+59.9% avg upside
18 analysts
|
β | +12.2% | Β· |
|
LNSR
LENSAR
|
Aug 20, 2026 | BUY |
Strong Buy
+135.5% avg upside
4 analysts
|
$10.00
71.28% Upside
|
-41.8% | Β· |
|
ORGO
Organogenesis Holdings
|
Aug 07, 2026 | HOLD |
Strong Buy
+1401.6% avg upside
8 analysts
|
β | -56.5% | Β· |
|
RXST
RxSight
|
Aug 06, 2026 | HOLD |
Hold
+86.0% avg upside
13 analysts
|
β | -20.6% | Β· |
|
HUMA
Humacyte
|
Jul 28, 2026 | BUY |
Strong Buy
+1468.9% avg upside
11 analysts
|
$2.00
386.41% Upside
|
-20.6% | Β· |
|
STAA
Staar Surgical
|
Jul 16, 2026 | HOLD |
Buy
+42.3% avg upside
16 analysts
|
β | -10.2% | Β· |
|
PEN
Penumbra
|
Jul 10, 2026 | HOLD |
Buy
+3.6% avg upside
23 analysts
|
β | +0.8% | Β· |
|
MOBI
Mobia Medical, Inc.
|
Jun 22, 2026 | BUY |
Strong Buy
+96.1% avg upside
4 analysts
|
$19.00
79.66% Upside
|
-9.1% | Β· |
|
MDAI
Spectral AI
|
May 26, 2026 | BUY |
Strong Buy
+186.0% avg upside
4 analysts
|
$4.00
161.40% Upside
|
-43.0% | Β· |
|
VCEL
Vericel
|
Apr 05, 2026 | HOLD |
Strong Buy
+16.2% avg upside
16 analysts
|
β | +68.7% | Β· |
|
XTNT
Xtant Medical Holdings
|
Mar 31, 2026 | BUY |
Strong Buy
+1928.2% avg upside
9 analysts
|
$1.00
256.93% Upside
|
-62.5% | Β· |
|
CH:ALC
Alcon
|
Mar 23, 2026 | BUY |
Strong Buy
+19.4% avg upside
36 analysts
|
$75.79
28.23% Upside
|
+5.0% | Β· |
|
RBOT
Vicarious Surgical
|
Nov 13, 2025 | HOLD |
Buy
+147829.0% avg upside
6 analysts
|
β | Β· | Β· |
|
TMCI
Treace Medical Concepts
|
Nov 07, 2025 | HOLD |
Hold
+34.6% avg upside
8 analysts
|
β | -9.8% | Β· |
|
OFIX
Orthofix Medical
|
Feb 25, 2025 | HOLD |
Buy
+203.8% avg upside
15 analysts
|
β | -25.5% | Β· |
|
IRTC
Irhythm Technologies
|
Oct 16, 2023 | BUY |
Strong Buy
+32.2% avg upside
21 analysts
|
$132.00
6.98% Upside
|
-26.8% | Β· |
|
AXGN
AxoGen
|
Aug 18, 2023 | HOLD |
Strong Buy
-17.4% avg upside
21 analysts
|
β | +104.0% | Β· |
|
PODD
Insulet
|
Apr 17, 2023 | BUY |
Strong Buy
+40.0% avg upside
32 analysts
|
$350.00
133.93% Upside
|
-48.2% | Β· |
|
GE
GE Aerospace
|
Apr 10, 2023 | HOLD |
Strong Buy
-22.8% avg upside
50 analysts
|
β | +108.4% | Β· |
|
MDWD
Mediwound
|
Oct 14, 2022 | HOLD |
Strong Buy
+64.6% avg upside
13 analysts
|
β | -3.7% | Β· |
|
ECOR
Electrocore
|
Jul 30, 2021 | HOLD |
Strong Buy
+497.2% avg upside
11 analysts
|
β | -44.6% | Β· |
|
ABT
Abbott Laboratories
|
Aug 27, 2020 | HOLD |
Strong Buy
+8.5% avg upside
36 analysts
|
β | +13.6% | Β· |
|
OCGN
Ocugen
|
Dec 24, 2018 | HOLD |
Strong Buy
+1211.8% avg upside
17 analysts
|
β | -95.0% | Β· |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.